Home / Stocks / KIMIABL
Back to all stocks
BSE · KIMIABL

KIMIA BIOSCIENCES LIMITED (KIMIABL) Share Price

Sector: Healthcare · ISIN: INE285U01025

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,634
of 5,047 stocks
▲ 581W▲ 221M
Peak #2,611 · 11 Oct 2026

A microcap name in Healthcare, KIMIA BIOSCIENCES LIMITED generates a high return on equity, remains firmly promoter-controlled, with promoters holding 75%, and is seeing revenue slip. Ownership as of Jun 2026.

Market Cap
158.40 Cr
P/E Ratio
20.41
P/B Ratio
8.93
ROE
41.95%
ROCE
28.50%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

MetricQ2 2026-27Q1 2026-27Q4 2025-26Q3 2025-26
Revenue26.81 Cr20.72 Cr27.20 Cr30.10 Cr
Net Profit2.39 Cr35.58 L37.31 L5.44 Cr
EPS0.500.080.151.15
Operating Profit3.45 Cr1.32 Cr2.52 Cr5.80 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter
74.94%
Public
25.06%

PUBLIC BREAKDOWN

DII
0.38%
MF (within DII)
0.38%
Individuals
24.02%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-DateTypeDetails
15 Nov 2018OtherReduction of Capital

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs